SeaStar Medical Holding (ICU) EBITDA (2021 - 2026)
SeaStar Medical Holding's (ICU) quarterly EBITDA came in at -$3.6 million in Q1 2026, up 5.73% YoY from -$3.4 million in Q1 2025, and down 19.46% on a QoQ basis from -$3.0 million in Q4 2025.
SeaStar Medical Holding (ICU) EBITDA (2021 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has 6 years of EBITDA data on file, last reported at -$3.6 million in Q1 2026.
- Quarterly EBITDA rose 5.73% year-over-year to -$3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$12.0 million (up 32.52% YoY) and the FY2025 annual result came in at -$12.2 million, up 31.76% from the prior year.
- EBITDA eased to -$3.6 million in Q1 2026, from -$3.0 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of -$812000.0 in Q1 2022 to a low of -$7.7 million in Q4 2022.
- A 5-year average of -$3.5 million and a median of -$3.6 million in 2026 frame the typical range for EBITDA.
- Annual changes were most pronounced in 2022 — EBITDA slumped 544.66% — and 2025, when it soared 62.39%.
- Tracing ICU's EBITDA over 5 years: stood at -$7.7 million in 2022, then soared by 61.94% to -$2.9 million in 2023, then tumbled by 62.31% to -$4.8 million in 2024, then soared by 36.73% to -$3.0 million in 2025, then fell by 19.46% to -$3.6 million in 2026.
- The last three EBITDA figures came in at -$3.6 million (Q1 2026), -$3.0 million (Q4 2025), and -$3.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | 231.44 Mn |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn | -375.75 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -1.55 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | 133.12 Mn |
| 10 | SeaStar Medical Holding | 13.89 Mn | 6.89 Mn | 561,000.00 | -3.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.79 Mn |
| Mar 31, 2026 | -3.60 Mn |
| Dec 31, 2025 | -3.02 Mn |
| Sep 30, 2025 | -3.58 Mn |
| Jun 30, 2025 | -1.76 Mn |
| Mar 31, 2025 | -3.82 Mn |
| Dec 31, 2024 | -4.77 Mn |
| Sep 30, 2024 | -4.46 Mn |
| Jun 30, 2024 | -4.67 Mn |
| Mar 31, 2024 | -3.95 Mn |
| Dec 31, 2023 | -2.94 Mn |
| Sep 30, 2023 | -2.94 Mn |
| Jun 30, 2023 | -3.75 Mn |
| Mar 31, 2023 | -4.58 Mn |
| Dec 31, 2022 | -7.72 Mn |
| Sep 30, 2022 | -1.77 Mn |
| Jun 30, 2022 | -1.31 Mn |
| Mar 31, 2022 | -812,000.00 |
| Dec 31, 2021 | -3.70 Mn |
| Sep 30, 2021 | -411,398.00 |